Even if the new body focuses on long-term planning, it is unlikely to do so through five-year Plans.
For PPP projects, clause on consent requirement could be abolished or brought down to 50% of land owners, against the current 70%
India has around 600,000 villages spread across the country.
If the presentation made by the Commission to the chief ministers is followed in letter and spirit, central sector and sponsored schemes will no longer be the domain of central ministries alone.
Sanjeeb Mukherjee, who was eight years old when the deadly gas leaked from Union Carbide's factory, gives his account of living in the city during that fateful period
When Prime Minister Narendra Modi recently extended a Rs 8,000-crore (Rs 80 billion) central support for building roads in Jammu & Kashmir, Union Cabinet's approval for the big-ticket announcement came in barely 48 hours.
The NDA is looking to reduce fiscal deficit not by chopping social sector spending but by paring it down
NPPA suggests expanding the list of essential medicines whose prices are controlled
Domestic and foreign companies pour in a slew of investments in Gujarat.
The state government has formed two committees under the chief secretary and the cane commissioner on the matter.
Sun maintained it would retain the best of both organisations to build a global pharma company.
A source said the competition watchdog would by next month suggest 'structural remedies' that included selling key drug segments as conditions for clearing the country's largest pharmaceutical industry merger.
US country head, key departmental heads leave; more likely to follow.
Competition in the US pharmaceutical market swelled in recent years, with increasing generic penetration.
No Ebola case detected in the country so far; experts say a robust preparedness plan to fight the virus missing.
Details on prices sought as 10 generic drugs become up to 83 times costlier in 6 months
PMO being sent daily updates on food cost situation in four major metropolitan cities to ensure no unusual flare-up.
Currently, the govt directly caps prices of 348 formulations at the average price of all medicines in a particular segment with at least 1% market share
The move is aimed at reflecting the diversity of India and highlighting the contribution of prominent personalities.
Among the companies likely to sign deals with Gilead are Cadila, Hetero, Strides Arcolab and Mylan, while Cipla is expected to earn active pharmaceutical ingredient rights.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances